Operating highlights16 Sep 2019 08:43
From today's RNS
Robust private growth of 4.1% sustained from H2 18.
Positive momentum on quality improvements with new Manchester hospital rated Outstanding. 81% of sites rated Good, Outstanding or equivalent (up from 74% in H1 18, 79% at FY18).
Long term pricing agreements signed with AXA PPP Healthcare and Bupa supporting our strategic focus on private patients
Digital strategy implementation underway with further rollout of consultant online booking, a successful pilot launch of the MySpire patient portal and a new Consultant App.
Purpose, our new cultural initiative to raise team engagement and our patient focus, launched across all hospitals and central functions
Group financial performance
3.4% revenue growth to £491.6m (2018: £475.6m)
Growth across all three payor groups: PMI sales rose 5.1%, Self-pay +1.4% and NHS +2.5%
Operating Profit growth to £51.0m (2018: £37.2m)
Net bank debt(4) lowered, with covenant leverage at 3.3x EBITDA (3.3x at end Dec 18, 3.0x at end June 18) versus limit of 4.0x
An interim dividend of 1.3 pence per ordinary share has been approved by the Board.
Justin Ash, Chief Executive Officer of Spire Healthcare, said: "This was a good performance with clear signs of our strategic and operational initiatives bearing fruit. We promised 2019 would be a year of stabilisation with revenue growth, continued quality improvement, cash generation and net debt reduction. All have been achieved in H1, with good operating profit performance.